Podlekareva, D., Bannister, W., Mocroft, A., Abrosimova, L., Karpov, I., Lundgren, J. D., Kirk, O. & EuroSIDA Study Group (Lars Østergaard, member) (2008).
The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results.
Central European Journal of Public Health,
16(3), 99-105.
Melchjorsen, J., Paludan, S. R., Mogensen, T., Tolstrup, M. & Østergaard, L. J. (2008).
TLR-mediated NF-kB-dependent cytokine production is differently affected by HIV therapeutics. Poster session presented at Toll2008 meeting, Lissabon, Portugal.
Bannister, W. P., Cozzi-Lepri, A., Clotet, B., Mocroft, A., Kjaer, J., Reiss, P., von Wyl, V., Lazzarin, A., Katlama, C., Phillips, A. N., Ruiz, L., Lundgren, J. D. & EuroSIDA Study Group (Lars Østergaard, member) (2008).
Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.
Journal of Acquired Immune Deficiency Syndromes (1999),
48(3), 324-33.
https://doi.org/10.1097/QAI.0b013e31817ae5c0
Bjerregaard-Andersen, M., da Silva, Z., Ruhwald, M.
, Andersen, P. L., Sodemann, M., Gustafson, P., Aaby, P.
& Wejse, C. (2008).
Tuberculosis burden in an urban cohort; a cross sectional tuberculosis survey from Guinea Bissau, West Africa. Abstract from 7
th International Conference of Pathogenesis of Mycobacterial Infections, Stockholm, Sweden.
Fox, Z., Phillips, A., Cohen, C., Neuhaus, J., Baxter, J., Emery, S., Hirschel, B., Hullsiek, K. H., Stephan, C., Lundgren, J., SMART Study Group
& Østergaard, L. J. (2008).
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.
AIDS,
22(17), 2279-89.
https://doi.org/10.1097/QAD.0b013e328311d16f
Lagging, M., Langeland, N., Pedersen, C., Färkkilä, M.
, Buhl, M. R., Mørch, K., Dhillon, A. P., Alsiö, A., Hellstrand, K., Westin, J., Christensen, P.
, Leutscher, P., Norkrans, G. & NORDynamIC Study Group (2008).
Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection.
Hepatology,
48(2), 695.
https://doi.org/10.1002/hep.22450